Fluticasone-salmeterol 230-21 12GM
Ended Awarded
- Contract number
- SPE2DR26FT769
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,221
Award facts
- Contract value 100% obligated
- $12,221.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,221.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone-Salmeterol 230-21 12GM pharmaceutical products on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside contract represents a competitive award to the prime contractor, headquartered in Conshohocken, Pennsylvania, and will be performed at the same location. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves critical federal medical procurement needs for military and veteran healthcare systems. The company's SPE2DX contract encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, supporting customers such as the Defense Health Agency and U.S. Coast Guard. This delivery order for Fluticasone-Salmeterol, a common respiratory combination medication, exemplifies the company's role as a key supplier within DLA's Medical Supply Chain and demonstrates its capability to fulfill federal pharmaceutical requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FT769?
SPE2DR26FT769 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FT769 worth?
The government has obligated $12,221 on SPE2DR26FT769.
Is contract SPE2DR26FT769 an order under another contract?
Yes. SPE2DR26FT769 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT769 competed?
The extent of competition for SPE2DR26FT769 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award